These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 28178698

  • 1. Dipeptidyl Peptidase-4 Inhibitors in Chronic Kidney Disease: A Systematic Review of Randomized Clinical Trials.
    Walker SR, Komenda P, Khojah S, Al-Tuwaijri W, MacDonald K, Hiebert B, Tangri N, Nadurak SWD, Ferguson TW, Rigatto C, Tangri N.
    Nephron; 2017; 136(2):85-94. PubMed ID: 28178698
    [Abstract] [Full Text] [Related]

  • 2. Comparison of efficacy and safety of three novel hypoglycemic agents in patients with severe diabetic kidney disease: A systematic review and network meta-analysis of randomized controlled trials.
    Li Y, Hu Y, Huyan X, Chen K, Li B, Gu W, Mu Y.
    Front Endocrinol (Lausanne); 2022; 13():1003263. PubMed ID: 36353233
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. DPP-4 Inhibitors in Diabetic Patients with Chronic Kidney Disease and End-Stage Kidney Disease on Dialysis in Clinical Practice.
    Abe M, Okada K.
    Contrib Nephrol; 2015; 185():98-115. PubMed ID: 26023019
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
    Karagiannis T, Paschos P, Paletas K, Matthews DR, Tsapas A.
    BMJ; 2012 Mar 12; 344():e1369. PubMed ID: 22411919
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis.
    Stoimenis D, Karagiannis T, Katsoula A, Athanasiadou E, Kazakos K, Bekiari E, Matthews DR, Tsapas A.
    Expert Opin Pharmacother; 2017 Jun 12; 18(9):843-851. PubMed ID: 28448177
    [Abstract] [Full Text] [Related]

  • 17. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk.
    Rosenstock J, Perkovic V, Alexander JH, Cooper ME, Marx N, Pencina MJ, Toto RD, Wanner C, Zinman B, Baanstra D, Pfarr E, Mattheus M, Broedl UC, Woerle HJ, George JT, von Eynatten M, McGuire DK, CARMELINA® investigators.
    Cardiovasc Diabetol; 2018 Mar 14; 17(1):39. PubMed ID: 29540217
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trials.
    Tran S, Retnakaran R, Zinman B, Kramer CK.
    Diabetes Obes Metab; 2018 Feb 14; 20 Suppl 1():68-76. PubMed ID: 29364587
    [Abstract] [Full Text] [Related]

  • 19. Short-term and long-term effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus patients with renal impairment: a meta-analysis of randomized controlled trials.
    Li R, Wang R, Li H, Sun S, Zou M, Cheng G.
    Diabetes Metab Res Rev; 2016 Sep 14; 32(6):460-9. PubMed ID: 26433213
    [Abstract] [Full Text] [Related]

  • 20. Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.
    Bae JH, Kim S, Park EG, Kim SG, Hahn S, Kim NH.
    Endocrinol Metab (Seoul); 2019 Mar 14; 34(1):80-92. PubMed ID: 30912341
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.